AstraZeneca
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.About AZN
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology.
AZN Key Statistics
Stock Snapshot
With a market cap of 254.73B, AstraZeneca(AZN) trades at $164.21. The stock has a price-to-earnings ratio of 24.66 and currently yields dividends of 1.68%.
On 2026-09-29, AstraZeneca(AZN) stock moved within a range of $163.24 to $168.45. With shares now at $164.21, the stock is trading +0.6% above its intraday low and -2.5% below the session's peak.
Trading activity shows a volume of 2.46M, compared to an average daily volume of 2.83M.
Over the past 52 weeks, AstraZeneca(AZN) stock has traded between a high of $212.71 and a low of $147.37.
Over the past 52 weeks, AstraZeneca(AZN) stock has traded between a high of $212.71 and a low of $147.37.
AZN News
H.C. Wainwright analyst Mitchell Kapoor has reiterated their neutral stance on SMMT stock, giving a Hold rating today. Mitchell Kapoor has given his Hold ratin...
Technology AstraZeneca Pays $2 Billion To Get Into High-Profile Cancer Space Licensing Summit Therapeutics (SMMT) stock catapulted Tuesday after AstraZeneca (AZ...
AstraZeneca Plc (NYSE:AZN) on Tuesday agreed to invest $2 billion in newly issued equity in Summit Therapeutics Inc. (NASDAQ:SMMT) to accelerate the development...
Analyst ratings
100%
of 10 ratingsMore AZN News
Sstock futures have edged higher in early trading as technology stocks stabilize, but elevated oil prices and Treasury yields tied to ongoing Middle East tensio...
Summit Therapeutics (SMMT) stock is up 22% in Tuesday’s premarket trading. The gain came after AstraZeneca (AZN) announced a $2 billion equity investment in Sum...
Shares of Summit Therapeutics Inc. (NASDAQ: SMMT) surged about 20% premarket on Tuesday after AstraZeneca Plc (NYSE: AZN) said it was going to invest $2 billion...
Graham Parry, an analyst from Citi, maintained the Buy rating on AstraZeneca. The associated price target remains the same with £178.00. Graham Parry has given...
...
AstraZeneca is investing $2 billion into Summit Therapeutics as part of an expanded partnership. Avishek Das / Zuma Press AstraZeneca AZN -0.48 %decrease; down...
Summit (SMMT) and AstraZeneca (ANZ) announced on Monday that the companies have entered into an agreement whereby AstraZeneca will make an equity investment of...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.